Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): In-depth sinus surgery analysis.

Wytske Johanna FokkensJoaquim MullolDavid KennedyCarl Martin PhilpottVeronica SecciaRobert C KernAndré CosteAna R SousaPeter J HowarthVictoria S BensonBhabita MayerSteve W YanceyRobert ChanSimon B Gane

Published in: Allergy (2022)

Mepolizumab reduced the risk of further sinus surgery in patients with recurrent, refractory, severe CRSwNP, irrespective of the patient baseline characteristics assessed.

Keyphrases

chronic rhinosinusitis
minimally invasive
coronary artery bypass
surgical site infection
case report
early onset
percutaneous coronary intervention
atrial fibrillation